Overall, this study shows, for the first time, miR-182-5p overexpression and Cyld-Foxo1 downregulation in hepatic tissues and tumors from a diet-induced NAFLD/HCC mouse model. The gene discussed is FOXO1; the disease is metabolic dysfunction-associated steatotic liver disease.